Ageing skin can lose its structural proteins (collagen and elastin), which causes it to begin to sag and become lax, therefore contributing to a tired and aged look.
Ellansé works differently and naturally. Thanks to its unique properites, it not only corrects wrinkles and folds but also stimulates your own collagen production to really treat the underlying causes of facial ageing. The effects are gradual and longer-lasting giving you a natural youthful appearance.
Real Patients, Real Results
Signs of agening
Deep facial lines & wrinkles
Undefined & uncontoured jawline
After 12 months of Ellansé
Softened nasolabial folds
Jawline definition recreated
Volume replenished on cheeks and temple
Treatment carried out by Dr Sophie Converset, Plastic surgeon (Lyon, France). Untouched image of an actual patient. Individual results may vary.
The first of a new class of dermal fillers, Ellansé naturally regenerates volume and restores the shape that time has taken away.
82% of Patients were satisfied with Ellansé 24 Months after Treatment with 78% of patients wanting to repeat Ellansé Treatment.
How Long Does Ellansé Last?
You will get natural looking and immediate results, that last from 1 to 4** years depending on which Ellansé option your physician recommends to you. The correction is maintained for the duration of the option.
Ellansé, a novel dermal filler consists of a unique and patented composition – 70% Carboxymethyl Cellulose (CMC) based gel carrier and 30% PolyCaproLactone (PCL) microspheres. Ellansé provides:
Beyond filling and beyond collagen stimulation
A novel dermal filler has dual benefits of immediate aesthetic correction and long lasting results by new collagen formation.
Tuneable longevity for sustained performance
Longevity (duration of action) is controlled and tuned with the ELLANSÉ family (S, M, L, E) from 1 to 4 years**
Highly effective treatment with superior safety profile
In a review of adverse events from launch to December 2017, the adverse event rate was 0.0565% or 1 event in 1769 syringes
*Moers-Carpi MM, Sherwood S. Polycaprolactone for the correction of nasolabial folds: a 24-month, prospective, randomised, controlled clinical trial. Dermatol Surg. 2013;39 (3 Pt 1):457-63. Journal of Cosmetic Dermatology.
**Expected longevity in-vivo based on extrapolation of clinical data from –S (1 year) and –M (2 years) accepted PCL degradation behaviour.